While advances in the understanding of the mechanisms leading to gout have informed interventions with xanthine oxidase-targeting molecules, like allopurinol, further advancements in the understanding of the molecular manifestations of this disease are necessary to advance more successful interventions beyond the treatment of gout [6]. This evidence concerns the gene XDH and gout.